Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tirofiban in Acute Ischemic Stroke
NCT04491695Phase 3Unknown
- Sponsor
- Capital Medical University
- Start
- Sep 2020
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tirofiban in ischemic stroke, sponsored by Capital Medical University. Status: unknown.
02
Drugs
tirofiban
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT04491695.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04491695.